Stockreport

Investors unmoved with TRACON Pharma's TRC105 in mid-stage liver cancer study; shares down 7% [Seeking Alpha]

TRACON Pharmaceuticals, Inc.  (TCON) 
Last tracon pharmaceuticals, inc. earnings: 2/27 04:03 pm Check Earnings Report
US:NASDAQ Investor Relations: traconpharma.com
PDF Investors unmoved with TRACON Pharma's TRC105 in mid-stage liver cancer study; shares down 7%Preliminary results from an ongoing Phase 1b/2 clinical trial assessing TRAC [Read more]